Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
HISA's $230M program faces scrutiny for failing to reduce horse deaths, cut doping, or ensure transparency.
An independent assessment by the ARCI questions whether HISA’s nearly $230 million cost is justified, noting equine fatality rates have remained nearly unchanged at around 99.9% through mid-2025.
Anti-doping tests dropped 46% from 2022 to 2024 despite fewer races, and no new doping agents have been found.
TCO2 testing rose sharply, making up 31% of tests but only 4% of adverse findings.
Uniform rules exist, but compliance with vet and location reporting is inconsistent.
HISA’s AI system lacks transparency, and the agency operates without public records or open meetings.
ARCI President Ed Martin criticized HISA’s rushed creation without congressional review, citing rising costs, litigation, and industry division, and called for reform or replacement.
El programa de $ 230 millones de HISA se enfrenta al escrutinio por no reducir las muertes de caballos, reducir el dopaje o garantizar la transparencia.